AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 11.62 |
Market Cap | 13.98B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.73 |
PE Ratio (ttm) | -16.04 |
Forward PE | n/a |
Analyst | Hold |
Ask | 11.85 |
Volume | 6,831,214 |
Avg. Volume (20D) | 7,947,809 |
Open | 11.85 |
Previous Close | 11.80 |
Day's Range | 11.65 - 12.02 |
52-Week Range | 9.93 - 13.62 |
Beta | undefined |
About VTRS
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, end...
Analyst Forecast
According to 3 analyst ratings, the average rating for VTRS stock is "Hold." The 12-month stock price forecast is $14, which is an increase of 19.56% from the latest price.
Next Earnings Release
Analysts project revenue of $3.62B, reflecting a -5.38% YoY shrinking and earnings per share of 0.58, making a -6.45% decrease YoY.
2 months ago · seekingalpha.com
Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)Viatris Inc. (NASDAQ:VTRS ) UBS Global Healthcare Conference November 12, 2024 11:45 AM ET Company Participants Doretta Mistras - CFO Conference Call Participants Ashwani Verma - UBS Ashwani Verma Goo...
2 months ago · seekingalpha.com
Bargain Priced Viatris Reports Strong Q3 Earnings ResultsBargain Priced Viatris Reports Strong Q3 Earnings Results
2 months ago · seekingalpha.com
Viatris Ahead Of Q3 Earnings: No Longer A 'Screaming' Bargain, But Still A BuyViatris Inc. stock has experienced significant volatility since its 2020 inception, driven by disappointing early performance, asset sales, and fluctuating market expectations. Despite low P/E and P/S...